erythrosine has been researched along with Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis in 1 studies
Fluoresceins: A family of spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one derivatives. These are used as dyes, as indicators for various metals, and as fluorescent labels in immunoassays.
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: Group of systemic vasculitis with a strong association with ANCA. The disorders are characterized by necrotizing inflammation of small and medium size vessels, with little or no immune-complex deposits in vessel walls.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bertelli, R | 1 |
| Trivelli, A | 1 |
| Magnasco, A | 1 |
| Cioni, M | 1 |
| Bodria, M | 1 |
| Carrea, A | 1 |
| Montobbio, G | 1 |
| Barbano, G | 1 |
| Ghiggeri, GM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Use of IL-2 for Pediatric, Multi Drug Resistant, Idiopathic Nephrotic Syndrome[NCT02455908] | Phase 1/Phase 2 | 5 participants (Actual) | Interventional | 2012-02-29 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 other study available for erythrosine and Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
| Article | Year |
|---|---|
Failure of regulation results in an amplified oxidation burst by neutrophils in children with primary nephrotic syndrome.
Topics: Adolescent; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Monoclonal; Anti | 2010 |